Literature DB >> 16322238

Overcoming Fas-mediated apoptosis accelerates Helicobacter-induced gastric cancer in mice.

Xun Cai1, Calin Stoicov, Hanchen Li, Jane Carlson, Mark Whary, James G Fox, JeanMarie Houghton.   

Abstract

The initiating molecular events in Helicobacter-induced gastric carcinogenesis are not known. Early in infection, Fas antigen-mediated apoptosis depletes parietal and chief cell populations, leading to architectural distortion. As infection progresses, metaplastic and dysplastic glands appear, which are resistant to Fas-mediated apoptosis. These abnormal lineages precede, and are thought to be the precursor lesions of, gastric cancer. Acquisition of an antiapoptotic phenotype before transformation of cells suggests that loss of Fas sensitivity may be an early required trait for gastric cancer. We reasoned that forced Fas-apoptosis resistance would result in earlier and more aggressive gastric cancer in our mouse model. Fas antigen-deficient (lpr) mice or C57BL/6 wild-type mice were irradiated and reconstituted with C57BL/6 marrow forming partial lpr/wt chimera or wt/wt control mice, extending the life span of the lpr and ensuring a competent immune response to Helicobacter felis infection. Infected lpr/wt mice developed gastric cancer as early as 7 months after infection (compared with 15 months in wt/wt mice). At 10 months (90%) and 15 months (100%), mice developed aggressive invasive lesions. This earlier onset and more aggressive histology strongly argues that Fas-apoptosis resistance is an early and important feature of gastric cancer formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322238     DOI: 10.1158/0008-5472.CAN-05-1802

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Rodent models of Helicobacter infection, inflammation, and disease.

Authors:  Songhua Zhang; Steven F Moss
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Animal Models and Helicobacter pylori Infection.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

3.  Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia.

Authors:  Wataru Shibata; Shigeo Takaishi; Sureshkumar Muthupalani; D Mark Pritchard; Mark T Whary; Arlin B Rogers; James G Fox; Kelly S Betz; Klaus H Kaestner; Michael Karin; Timothy C Wang
Journal:  Gastroenterology       Date:  2009-12-04       Impact factor: 22.682

4.  Genetic variants in fas signaling pathway genes and risk of gastric cancer.

Authors:  Paula L Hyland; Shih-Wen Lin; Nan Hu; Han Zhang; Lemin Wang; Hua Su; Chaoyu Wang; Ti Ding; Ze-Zhong Tang; Jin-Hu Fan; You-Lin Qiao; Xiaoqin Xiong; William Wheeler; Carol Giffen; Kai Yu; Jeff Yuenger; Laurie Burdett; Zhaoming Wang; Stephen J Chanock; Margaret A Tucker; Sanford M Dawsey; Neal D Freedman; Alisa M Goldstein; Christian C Abnet; Philip R Taylor
Journal:  Int J Cancer       Date:  2013-09-11       Impact factor: 7.396

5.  Role of Helicobacter pylori on cancer of human adipose-derived mesenchymal stem cells and metastasis of tumor cells-an in vitro study.

Authors:  Sadegh Lotfalah Moradi; Gita Eslami; Hossein Goudarzi; Zahra Hajishafieeha; Masoud Soleimani; Adel Mohammadzadeh; Abdolreza Ardeshirylajimi
Journal:  Tumour Biol       Date:  2015-10-07

6.  Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to cisplatin.

Authors:  Fan Yang; Wang Long; Han Xuechuan; Liu Xueqin; Ma Hongyun; Ding Yonghui
Journal:  BMB Rep       Date:  2015-01       Impact factor: 4.778

Review 7.  Nature meets nurture: molecular genetics of gastric cancer.

Authors:  Anya N Milne; F Carneiro; C O'Morain; G J A Offerhaus
Journal:  Hum Genet       Date:  2009-08-06       Impact factor: 4.132

8.  bak deletion stimulates gastric epithelial proliferation and enhances Helicobacter felis-induced gastric atrophy and dysplasia in mice.

Authors:  C A Duckworth; A A Abuderman; M D Burkitt; J M Williams; L A O'Reilly; D M Pritchard
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-09       Impact factor: 4.052

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.